Search

Home > GRACEcast Lung Cancer Video > ASCO 2012 LC Highlights: Dr. Mark Socinski on Single Agent vs Doublet Chemo for PS2 (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

ASCO 2012 LC Highlights: Dr. Mark Socinski on Single Agent vs Doublet Chemo for PS2 (video)
Category: Science & Medicine
Duration: 00:06:50
Publish Date: 2012-08-19 07:44:03
Description:

Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.
Total Play: 0